FMW Media's New to The Street announces its corporate appearances
on episodes 479 and 480 on Newsmax and the FOX Business Network.
Newsmax airs Episode 779 Saturday, June
17, 2023, at 3:30 PM ET, featuring the following
corporate interviews:
1). Biotherapeutic Research – ImmunoPrecise
Antibodies Ltd.'s (NASDAQ: IPA) ($IPA) ("IPA") interview with Dr.
Jennifer Bath, CEO/President.
2). Pet Health – PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO &
President.
3). Life Sciences Industry Equipment - Pressure
BioSciences, Inc.'s (OTCQB: PBIO) ($PBIO) interview with Richard T.
Schumacher, President/CEO.
4). Wellness Solutions Technologies - Avenir
Wellness Solutions, Inc.'s (OTCQB: CURR) ($CURR) interview with
Nancy Duitch, CEO.
5). "Sekur Privacy & Sekur Security
Segment – The Weekly
Hack" interview with internet privacy expert Mr. Alain
Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR)
(FRA: GDT0) ($SWISF) (Sekur®).
FOX Business Network airs Episode 480
Monday, June 19, 2023, at 10:30 PM PT, featuring the following
Corporate Interviews:
1). Biotherapeutic Research – ImmunoPrecise
Antibodies Ltd.'s (NASDAQ: IPA) ($IPA) ("IPA") interview with Dr.
Jennifer Bath, CEO/President.
2). Pet Health – PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO &
President.
3). Life Sciences Industry Equipment - Pressure
BioSciences, Inc.'s (OTCQB: PBIO) ($PBIO) interview with Richard T.
Schumacher, President/CEO.
4). Wellness Solutions Technologies - Avenir
Wellness Solutions, Inc.'s (OTCQB: CURR) ($CURR) interview with
Nancy Duitch, CEO.
5). "Sekur Privacy & Sekur Security
Segment – The Weekly
Hack" interview with internet privacy expert Mr. Alain
Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR)
(FRA: GDT0) ($SWISF) (Sekur®).
From the Nasdaq MarketSite studio, New to The
Street airs TV Host Jane King's interview with Dr. Jennifer Bath,
Chief Executive Officer and President of ImmunoPrecise Antibodies,
Ltd. (NASDAQ: IPA) ($IPA) ("IPA"). IPA is a biotherapeutic research
company that combines industry-leading antibody discovery services
and complex artificial intelligence technologies. For about 30
years, the Company has helped create novel drug therapeutics and
methods for oncology, inflammatory inflictions, and chronic and
deadly diseases. Hundreds of companies have used IPA as their
pharmaceutical partner in finding drug treatments. Dr. Bath talks
about the Company's BioStrand subsidiary and how it is advancing
IPA's existing platform in antibody AI-driven biotherapeutic
research and technology. Finding new drug candidates to solve
problems is often complex and, in some cases, impossible. Clients
come to IPA because of its advanced AI platform and seek solutions
that cannot be easily obtainable within their organization and
labs. Dr. Bath gives an example of how the Company's AI
biotherapeutic platform targets tumors' micron cellular levels.
Tumors change in shape, molecular composures, and cellular Ph
Levels within and around themselves. It is challenging to pinpoint
the source of these molecular changes, so IPA is working with a
client to develop and target tumor growth using the platform. The
on-screen QR code is available during the show; download or visit
ImmunoPrecise Antibodies, Ltd. ("IPA") -
https://www.ipatherapeutics.com/. The interview will air on
Newsmax, episode 479, on June 17, 2023, at 3:30 PM ET, and the FOX
Business Network, episode 480, on June 19, 2023, at 10:30 PM
PT.
John Lai, PetVivo Holdings, Inc.'s (NASDAQ:
PETV) (NASDAQ: PETVW) ($PETV) CEO/President, talks with New to The
Street's TV Host Jane King from the Nasdaq MarketSite studio.
PetVivo manufactures, commercializes, and licenses innovative
medical devices and pet therapeutics. The Company's patented
product, Spryng with OsteoCushion Technology, gives veterinarians a
tool to help pet owners manage their pets' osteoarthritis and
joint-related ailments. John tells viewers he is learning that
veterinarians use the product for other animal conditions. During a
recent trade conference in Charleston, South Carolina,
veterinarians talked to the Company about using Spryng with bone
marrow stem cells. The problem is that stem cell injections lose
about 80% effectiveness within the first 24 hours. These
veterinarians would like to collaborate using PETV's Spryng
clinical platform by introducing stem cells to achieve greater
treatment outcomes when using stem cells. Spryng is a matrix of
building block proteins injected into inflected joints, filling
voids of depleted cartilage. Spryng mimics collagen tissue that
significantly improves animals' afflicted joints. John tells
viewers that trade shows and conference appearances increase
veterinarians' understanding of the Company and its Spryng product.
The Company expects the clinical study on the feline Spryng product
to be out sometime in July 2023, and John will be back on-set to
discuss those results. The Company recently appointed a new Board
of Directors, Spencer Breithaupt, who brings 30+ years in the
animal health industry to the Company. Spencer recently retired
from MWI Animal Health, AmerisourceBergen where he held the
position of Vice-President of Sales/Supply-chain Management. He
also served as the Chairman of the Animal Health Corridor, an
organization that brings animal health industry professionals
together to address animal healthcare initiatives and innovations.
John feels that the caliber of Spencer's background and
achievements is an excellent endorsement for PetVivo's current and
future products in the pipeline. The on-screen QR code is available
during the show; download or visit PetVivo Holdings, Inc. -
https://petvivo.com/ & Spryng with OsteoCushion Technology -
https://www.sprynghealth.com/. The interview will air on Newsmax,
episode 479, on June 17, 2023, at 3:30 PM ET, and the FOX Business
Network, episode 480, on June 19, 2023, at 10:30 PM PT.
From the Nasdaq MarketSite studio, Richard T.
Schumacher, President/CEO of Pressure BioSciences, Inc. (OTCQB:
PBIO) ($PBIO), talks with New to The Street's TV Host Jane King
about the Company Pressure BioSciences, Inc. develops and sells
innovative extreme pressure-based platform technology solutions for
the global life sciences industry. The Company generates revenues
from its patented platforms: Pressure Cycling Technology ("PCT™"),
BaroFold™ Platform, and Ultra Shear Technology ("UltraShear™" or
"UST™"). Combining high-pressure and high shearing, Management and
its scientific team created a new era of delivering oil-based
nutrients and therapeutics. Richard tells viewers that about 44% of
all new pharmaceuticals are from oil-based derivatives. The human
body has difficulty absorbing oil molecules, so the Company's Ultra
Shear technology platform can make oil molecules smaller and more
absorbent. The Ultra Shear Platform can increase the efficacies of
cosmetics, vitamins, drugs, and other health products with higher
molecular absorptions. You often buy a product or get a drug from a
pharmacist with instructions stating "Shake" before using. PBIO
creates invisibly solubilized nanoemulsions particles of oil in
water that remain mixed, requiring no shaking. The Company recently
partnered with CBD Supply MD, a larger supplier of CBD
products in the multi-state mid-Atlantic region. Using PBIO
technological platform, CBD Supply announced the commercial
introduction and availability of their "NanoBloom CBD" Topical
Spray. The all-natural CBD Topical Spray delivers rock-solid
multi-year stability and is a leap forward in best-in-class,
super-fast acting, and highly bioavailable hemp-derived product.
The Company has 39 patents, and Management is looking into
non-dilutive financing through license agreements on its patents.
Richard expects to close on more contracts and sees strong growth
for the Company's UltraShear and other products. The on-screen QR
code is available during the show; download or visit Pressure
BioSciences, Inc. - https://www.pressurebiosciences.com/. The
interview will air on Newsmax, episode 479, on June 17, 2023, at
3:30 PM ET, and the FOX Business Network, episode 480, on June 19,
2023, at 10:30 PM PT.
New to The Street's TV Host Jane King, from the
Nasdaq MarketSite Studio, talks with Nancy Duitch, CEO
of Avenir Wellness Solutions, Inc. (f/k/a - CURE
Pharmaceutical Holding Corp.) (OTCQB: CURR) ($CURR) ("Avenir").
Avenir is a wellness solutions technology Company that creates and
markets wellness consumer products. Nancy talks about the Company's
most recently launched product, DNA Complex – Deep Nano-Active
Complex. Rob Davidson, Chief Science Officer, and Creator of DNA
Complex, created the product which makes wrinkles disappear. After
many lab trials, Rob developed an encapsulation peptide formulation
that absorbs directly into the skin and leaves no white films.
Competitor products lay atop the skin without immediate direct
absorption and typically leave residues. The Company launched the
product the night of the 2023 Oscar Awards with Hollywood Star
Nicole Kidman, a global brand ambassador, who used the product
while attending the award show. Her makeup artist raved about the
product, and his review of DNA Complex was in many magazines.
theSkimm', a well-known women’s beauty and wellness publication,
wrote about the product, which has increased consumer awareness
about the DNA Complex, with the Company receiving many requests for
the product. During her interview, Nancy shows pictures of women
using the product with before and after results. Consumers
searching the Company's website Sera Labs, Inc. ("Sera Labs") are
purchasing DNA Complex and other product offerings. Nancy offers
PROMO CODE: VIPTV20; go to the DNA Complex landing
page - https://seralabshealth.com/pages/dna-complex-landing. The
on-screen QR code is available during the show; download or visit
Avenir Wellness Solutions, Inc. - https://www.avenirwellness.com/
and Sera Labs, Inc. ("Sera Labs") – https://seralabshealth.com/.
The interview will air on Newsmax, episode 479, on June 17, 2023,
at 3:30 PM ET, and the FOX Business Network, episode 480, on June
19, 2023, at 10:30 PM PT.
New to The Street's "Sekur Privacy &
Sekur Security Segment – The Weekly Hack" has Alain Ghiai,
internationally acclaimed internet privacy expert and the CEO of
Sekur Private Data, Ltd.
(OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) and TV Host/Multi-media
Journalist Ana Berry talking about another cybersecurity topic.
German government IT contractors have hacked their systems giving
access to Germany's sensitive and private governmental data. Alain
says these types of cybersecurity issues occur not just in Germany
but worldwide. Many Governments use 3rd party IT providers to
assist them in operations; the hackers seek the weakest level and
institute a breach. Sekur has its "Sekur Enterprise Solutions"
designed for business and governmental organizations, which can
assist in minimizing cybersecurity threats. The solution has IT
management solutions for C-suite executives and employees, with
message and email archiving and mass onboarding features. Alain
explains further the benefits, whereas a C-suite executive's email
is on Sekur's private and secure network while keeping employees'
emails hosted on a company's existing platform.
SekurSend/SekurReply email and messenger features are available in
Sekur Enterprise Solutions. Any business and governmental entity
interested in learning more can contact Sekur for assistance. Sekur
expects to launch its "Sekur Enterprise Solutions" in July/August
2023. Alain is still offering PROMO CODE: PRIVACY,
a 15% savings monthly and yearly on all the Company's service
plans. The discount will remain active for five years for
uninterrupted subscribers. Demand for cybersecurity products
continues to grow as people seek lifestyle changes to protect
themselves from hackers and other cybersecurity threats. Sekur
Private Data, Ltd. operates its internet platforms and security
businesses under the country of Switzerland's very tough privacy
laws. It never data mines, sells data or asks for a phone number.
The on-screen QR code is available during the show to download more
info or visit Sekur Private Data, Ltd.-
https://www.sekurprivatedata.com/, http://www.Sekur.com, and
https://www.sekurvpn.com/. "Privacy Has Arrived."
The interview will air on Newsmax, episode 479, on June 17, 2023,
at 3:30 PM ET, and the FOX Business Network, episode 480, on June
19, 2023, at 10:30 PM PT.
About ImmunoPrecise
Antibodies Ltd. (NASDAQ: IPA)
($IPA) ("IPA"): ImmunoPrecise Antibodies Ltd. (NASDAQ:
IPA) ($IPA) ("IPA") has several subsidiaries in North America and
Europe, including entities such as Talem Therapeutics LLC,
BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd., and
ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA
Family"). The IPA Family is a biotherapeutic research and
technology group that leverages systems biology, multi-omics
modeling, and complex artificial intelligence systems to support
its proprietary technologies in bioplatform-based antibody
discovery. Services include highly specialized, full-continuum
therapeutic biologics discovery, development, and out-licensing to
support its business partners in discovering and developing novel
biologics against the most challenging targets -
www.ipatherapeutics.com.
About Avenir
Wellness Solutions,
Inc. (OTCQB: CURR)
($CURR): Avenir Wellness Solutions, Inc. (OTCQB: CURR)
($CURR) is a broad platform technology company that develops
proprietary wellness, nutraceutical, and topical delivery systems.
Based on (15) fifteen current patents, the technology offers
numerous unique immediate- and controlled-release delivery vehicles
designed to improve product efficacy, safety, and consumer
experience for a wide range of active ingredients. The Company will
continue to create new technologies that will be part of its
incubator strategy to monetize its IP. As a vertically integrated
platform company, Avenir looks to partner or license its IP
technology with wellness companies worldwide -
https://www.avenirwellness.com/.
About The Sera Labs,
Inc.:
The Sera Labs, Inc. ("Sera Labs"), a wholly
owned subsidiary of Avenir, is a trusted leader in the health,
wellness, and beauty sectors of innovative products with
cutting-edge technology. Sera Labs creates high-quality products
that use science-backed, proprietary formulations. More than 25
products are sold under the brand names Seratopical™, Seratopical
Revolution™ SeraLabs™, and Nutri-Strips™. Sera Labs sells its
products at affordable prices, making them easily accessible on a
global scale. Strategically positioned in the growth market
categories of beauty, health & wellness, Sera Labs products are
sold in major national drug, grocery chains, convenience stores,
and mass retailers. Sera Labs also sells products under private
labels to major retailers, multi-level marketers, and
direct-to-consumer (DTC) via online website orders, including
opt-in subscriptions. For more information
visit: https://seralabshealth.com/ and follow Sera Labs on
Facebook and Instagram at @seratopical, and on Twitter at @sera_
labs.
About PetVivo Holdings,
Inc. (NASDAQ: PETV) (NASDAQ: PETVW)
($PETV):
PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ:
PETVW) ($PETV) is an emerging biomedical device company currently
focused on the manufacturing, commercialization, and licensing of
innovative medical devices and therapeutics for companion animals.
The Company's strategy is to leverage human therapies for treating
companion animals in a capital and time-efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for treating animals
and people. A portfolio of nineteen patents protects the Company's
biomaterials, products, production processes, and use methods. The
Company's lead product Spryng™ with
OsteoCushion™ technology, a veterinarian-administered,
intraarticular injection for managing lameness and other
joint-related afflictions, including osteoarthritis, in dogs and
horses, is currently available for commercial sale -
https://petvivo.com/ and https://www.sprynghealth.com/.
About Pressure
BioSciences, Inc. (OTCQB: PBIO)
($PBIO):
Pressure BioSciences, Inc. (OTCQB: PBIO) ($PBIO)
is a global leader in providing innovative, broadly enabling,
high-pressure-based solutions for a range of industries, including
biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and
agrochemical, as well as food and beverage manufacturing. The
Company's products utilize both constant and alternating pressure.
Its patented Pressure Cycling Technology (PCT) utilizes alternating
cycles of pressure to control bio-molecular interactions (such as
cell lysis and biomolecule extraction) safely and reproducibly.
PCT-based products are beginning to be widely used for biomarker
and target discovery, drug design, and development, biotherapeutics
characterization and quality control, soil & plant biology,
forensics, and counter-bioterrorism applications. PBIO recently
expanded its market opportunities by acquiring the BaroFold™
patented technology platform, allowing us to enter the bio-pharma
contract services and GMP manufacturing equipment sector. The
Company also developed the scalable and high-efficiency
pressure-based UltraShear Technology™ (UltraShear™) platform, which
creates stable nanoemulsions of otherwise immiscible fluids. It
also allows for preparing higher quality, homogenized, extended
shelf-life or room temperature-stable low-acid liquid foods that
cannot be effectively preserved using existing non-thermal
technologies. Management's commitment to innovation and
cutting-edge technology has established PBIO as a leader in the
high-pressure industry, providing unique and effective solutions to
our customers - https://www.pressurebiosciences.com/.
About Sekur Private Data
Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA:
GDT0):
Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) is a cybersecurity and internet privacy provider
of Swiss-hosted solutions for secure communications and secure data
management. The Company distributes a suite of secure cloud-based
storage, disaster recovery, document management, encrypted emails,
and secure communication tools. It sells its products through its
websites www.sekur.com, approved distributors, and
telecommunication companies worldwide. Sekur Private Data, Ltd.
serves consumers, businesses, and governments worldwide -
https://www.sekurprivatedata.com and https://www.sekur.com;
Twitter: @sekurprivate.
About New to The
Street:
New to The Street is an FMW Media production that
operates one of the longest-running US and International sponsored
and syndicated Nielsen Rated programming television brands, "New to
The Street," and its blockchain show, "Exploring The Block." Since
2009, these brands have run biographical interview segment shows
across major U.S. television networks. The paid-for-television
programming platforms can potentially reach millions of homes in
the US and international markets. FMW's New to The Street / Newsmax
televised broadcasting platform airs its syndication on Saturdays
at 3:30 – 4:00 PM ET. FMW is also one of the nation's largest
buyers of linear television, long and short-form paid programming
- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.
Forward-Looking Statements Disclaimer
US/Canada:
This press release contains forward-looking
statements within Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934. In
some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology.
However, not all forward-looking statements contain these words.
Forward-looking statements do not guarantee future performance or
results and will not necessarily be accurate indications of the
times at which such performance or results are achieved. This press
release should be considered in all filings of the Companies
contained in the Edgar Archives of the Securities and Exchange
Commission at www.sec.gov.
This press release contains forward-looking
information within the meaning of applicable Canadian securities
laws. Forward-looking information is often, but not always,
identified by the use of words such as "seek", "anticipate",
"believe", "plan", "estimate", "expect", "likely" and "intend" and
statements that an event or result "may", "will", "should", "could"
or "might" occur or be achieved and other similar expressions.
These statements reflect Management's current beliefs and are based
on information currently available to Management as of the date
hereof. Forward-looking information in this press release includes,
without limiting the foregoing, expectations regarding agents that
join Real.
CONTACT:
FMW Media Contacts: Monica Brennan
monica@NewtoTheStreet.com 1-917-330-2564
"New to The Street" Business Development Office
1-516-696-5900 Support@NewToTheStreet.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e12a76c4-5adb-4615-abeb-371fdad437d4
A video accompanying this announcement is available
at https://www.globenewswire.com/NewsRoom/AttachmentNg/dc2c3732-b6f7-479e-aef3-5740e90b30fa
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024